Insights

Loading spinner
Gathering insights about Amarantus BioScience

Amarantus BioScience Tech Stack

Amarantus BioScience uses 8 technology products and services including Amazon Web Services, Microsoft 365, Google Fonts API, and more. Explore Amarantus BioScience's tech stack below.

  • Amazon Web Services
    Cloud Hosting
  • Microsoft 365
    Email
  • Google Fonts API
    Font Scripts
  • jQuery
    Javascript Libraries
  • Modernizr
    Javascript Libraries
  • Bootstrap
    UI Frameworks
  • GoDaddy
    Web Hosting
  • Apache
    Web Servers

Media & News

Amarantus BioScience's Email Address Formats

Amarantus BioScience uses at least 1 format(s):
Amarantus BioScience Email FormatsExamplePercentage
FLast@amarantus.comJDoe@amarantus.com
28%
First.Last@amarantus.comJohn.Doe@amarantus.com
23%
First@amarantus.comJohn@amarantus.com
21%
FLast@amarantus.comJDoe@amarantus.com
28%

Frequently Asked Questions

Where is Amarantus BioScience's headquarters located?

Minus sign iconPlus sign icon
Amarantus BioScience's main headquarters is located at 675 Almanor Ave, c/o The Parkinson's Institute Sunnyvale, California 94085, US. The company has employees across 2 continents, including North AmericaEurope.

What is Amarantus BioScience's phone number?

Minus sign iconPlus sign icon
You can contact Amarantus BioScience's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Amarantus BioScience's official website and social media links?

Minus sign iconPlus sign icon
Amarantus BioScience's official website is amarantus.com and has social profiles on LinkedInCrunchbase.

What is Amarantus BioScience's SIC code NAICS code?

Minus sign iconPlus sign icon
Amarantus BioScience's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Amarantus BioScience have currently?

Minus sign iconPlus sign icon
As of October 2025, Amarantus BioScience has approximately 7 employees across 2 continents, including North AmericaEurope. Key team members include Chief Medical Officer: C. K.Chief Scientific Officer: J. C.Senior Vice President - Regulatory Affairs: C. S.. Explore Amarantus BioScience's employee directory with LeadIQ.

What industry does Amarantus BioScience belong to?

Minus sign iconPlus sign icon
Amarantus BioScience operates in the Biotechnology Research industry.

What technology does Amarantus BioScience use?

Minus sign iconPlus sign icon
Amarantus BioScience's tech stack includes Amazon Web ServicesMicrosoft 365Google Fonts APIjQueryModernizrBootstrapGoDaddyApache.

What is Amarantus BioScience's email format?

Minus sign iconPlus sign icon
Amarantus BioScience's email format typically follows the pattern of FLast@amarantus.com. Find more Amarantus BioScience email formats with LeadIQ.

How much funding has Amarantus BioScience raised to date?

Minus sign iconPlus sign icon
As of October 2025, Amarantus BioScience has raised $3M in funding. The last funding round occurred on Nov 17, 2014 for $3M.

When was Amarantus BioScience founded?

Minus sign iconPlus sign icon
Amarantus BioScience was founded in 2008.

Amarantus BioScience

Biotechnology ResearchUnited States2-10 Employees

Amarantus BioScience Holdings (OTCQB: AMBS) is a biotechnology company developing treatments and diagnostics for diseases in the areas of neurology, regenerative medicine and orphan diseases. AMBS owns the rights to Engineered Skin Substitute program, a regenerative medicine-based approach for treating severe burns with full thickness autologous skin grown in tissue culture. ESS is entering Phase 2 clinical studies under a CRADA agreement with the US Army, and is also preparing a pivotal development program for rare pediatric disease Giant Congenital Melanocytic Nevi. AMBS' also has licensing rights to eltoprazine, a Phase 2b-ready small molecule indicated for Parkinson's disease levodopa-induced dyskinesia, adult ADHD and Alzheimer's aggression, and owns the intellectual property rights to a therapeutic protein known as mesencephalic-astrocyte-derived neurotrophic factor and is developing MANF-based products as treatments for brain and ophthalmic disorders. 

AMBS' Diagnostics division owns the rights to MSPrecise®, a proprietary next-generation DNA sequencing (NGS) assay for the identification of patients with relapsing-remitting multiple sclerosis (RRMS) at first clinical presentation, has an exclusive worldwide license to the Lymphocyte Proliferation test (LymPro Test®) for Alzheimer's disease, which was developed by Prof. Thomas Arendt, Ph.D., from the University of Leipzig, and owns intellectual property for the diagnosis of Parkinson's disease (NuroPro). AMBS also owns the discovery of neurotrophic factors (PhenoGuard™) that led to MANF's discovery.

Amarantus is a Founding Member of Global Brain Health Coalition (GBHC). The GBHC mission is to become the leading global voice for brain health awareness and empowerment by converging science, clinical research and impact. The Company believes that TBI-induced neurodegeneration represents a new frontier of clinical research which may ultimately allow for commonalities between chronic degenerative disorders.

Section iconCompany Overview

Headquarters
675 Almanor Ave, c/o The Parkinson's Institute Sunnyvale, California 94085, US
Phone number
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2008
Employees
2-10

Section iconFunding & Financials

  • $3M

    Amarantus BioScience has raised a total of $3M of funding over 2 rounds. Their latest funding round was raised on Nov 17, 2014 in the amount of $3M.

  • $1M$10M

    Amarantus BioScience's revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $3M

    Amarantus BioScience has raised a total of $3M of funding over 2 rounds. Their latest funding round was raised on Nov 17, 2014 in the amount of $3M.

  • $1M$10M

    Amarantus BioScience's revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.